PTP1B inhibition studies of biological active phloroglucinols from the rhizomes of Dryopteris crassirhizoma: Kinetic properties and molecular docking simulation
- PMID: 34416263
- DOI: 10.1016/j.ijbiomac.2021.08.091
PTP1B inhibition studies of biological active phloroglucinols from the rhizomes of Dryopteris crassirhizoma: Kinetic properties and molecular docking simulation
Abstract
By various chromatographic methods, 30 phloroglucinols (1-30) were isolated from a methanol extract of Dryopteris crassirhizoma, including two new dimeric phloroglucinols (13 and 25). The structures of the isolates were confirmed by HR-MS, 1D, and 2D NMR as well as by comparison with the literature. The protein tyrosine phosphatase 1B (PTP1B) effects of the isolated compounds (1-30) were evaluated using sodium orthovanadate and ursolic acid as a positive control. Among them, trimeric phloroglucinols 26-28 significantly exhibited the PTP1B inhibitory effects with the IC50 values of 1.19 ± 0.13, 1.00 ± 0.04, 1.23 ± 0.05 μM, respectively. In addition, the kinetic analysis revealed compounds 26-28 acted as competitive inhibitors against PTP1B enzyme with Ki values of 0.63, 0.61, 1.57 μM, respectively. Molecular docking simulations were performed to demonstrate that these active compounds can bind with the catalytic sites of PTP1B with negative binding energies and the results are in accordance with that of the kinetic studies. In vitro and in silico results suggest that D. crassirhizoma rhizomes together with compounds 26-28 are potential candidates for treating type 2 diabetes.
Keywords: Dryopteris crassirhizoma rhizomes; Kinetic; Molecular docking; Phloroglucinols; Protein tyrosine phosphatase 1B.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Inhibitory Activity of Bioactive Phloroglucinols from the Rhizomes of Dryopteris crassirhizoma on Escherichia coli β-Glucuronidase: Kinetic Analysis and Molecular Docking Studies.Metabolites. 2022 Oct 2;12(10):938. doi: 10.3390/metabo12100938. Metabolites. 2022. PMID: 36295840 Free PMC article.
-
Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma.Molecules. 2017 Mar 8;22(3):431. doi: 10.3390/molecules22030431. Molecules. 2017. PMID: 28282885 Free PMC article.
-
Phloroglucinol Derivatives from Dryopteris crassirhizoma as Potent Xanthine Oxidase Inhibitors.Molecules. 2020 Dec 29;26(1):122. doi: 10.3390/molecules26010122. Molecules. 2020. PMID: 33383880 Free PMC article.
-
Polycyclic phloroglucinols as PTP1B inhibitors from Hypericum longistylum: Structures, PTP1B inhibitory activities, and interactions with PTP1B.Bioorg Chem. 2017 Dec;75:139-148. doi: 10.1016/j.bioorg.2017.09.001. Epub 2017 Sep 6. Bioorg Chem. 2017. PMID: 28946049
-
Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.J Ethnopharmacol. 2016 Dec 24;194:706-716. doi: 10.1016/j.jep.2016.10.007. Epub 2016 Oct 18. J Ethnopharmacol. 2016. PMID: 27769948
Cited by
-
Inhibitory Activity of Bioactive Phloroglucinols from the Rhizomes of Dryopteris crassirhizoma on Escherichia coli β-Glucuronidase: Kinetic Analysis and Molecular Docking Studies.Metabolites. 2022 Oct 2;12(10):938. doi: 10.3390/metabo12100938. Metabolites. 2022. PMID: 36295840 Free PMC article.
-
Regulating the expression of matrix metalloproteinases to inhibit ovarian carcinoma using isoquinoline alkaloid from Allium ascalonicum.Sci Rep. 2025 Mar 18;15(1):9228. doi: 10.1038/s41598-025-94111-0. Sci Rep. 2025. PMID: 40097575 Free PMC article.
-
Phenolic-based allosteric inhibition of PTP1B: unlocking new therapeutic potential for metabolic disorders.J Comput Aided Mol Des. 2025 Jun 24;39(1):35. doi: 10.1007/s10822-025-00616-1. J Comput Aided Mol Des. 2025. PMID: 40553177
-
Mechanism-Based Allosteric Inhibition of PTP1B by Prenylated Flavonoids from Glycyrrhiza echinata: In Vitro Experiments and in Silico Validation.Protein J. 2025 Jul 16. doi: 10.1007/s10930-025-10272-x. Online ahead of print. Protein J. 2025. PMID: 40668333
-
Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics.Front Cardiovasc Med. 2024 Aug 22;11:1445739. doi: 10.3389/fcvm.2024.1445739. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39238503 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous